Testing MOUD Scale-Up
University of Wisconsin, Madison · with National Institute on Drug Abuse (NIDA) · NCT07224516
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 120
- US sites recruiting
- 1
- Study start
- February 5, 2026
- Record last updated
- February 13, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to improve health outcomes for incarcerated individuals by increasing medications for opioid use disorder (MOUD) use, using scalable and cost-effective methods that could be applied more broadly in the criminal justice system.
Being studied: SAMHSA; Learning Collaborative
Conditions: Incarcerated Individuals; Correctional Institutions
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria - Sites
- Have an interest in embedding or increasing the use of MOUD within their site
- Have the funds to pay for medication for the duration of the study (24 months)
- Agree to implement or continue the use of at least one medication for opioid use disorder
- Have leadership support at all levels including from Secretary of DOC, medical director, wardens, etc.
- Sign a memorandum of Understanding (MOU) or Information Sheet
- Agree to provide data described in the Information Sheet
Exclusion Criteria
- Failure to meet eligibility criteria
Recruiting US locations
University of Wisconsin-Madison
Madison, WI 53706
Site contact: Jessica Vechinski · 414-899-4324 · jvechinski@wisc.edu
Study contacts (from the official record)
- Jessica Vechinski, MSW · 414-899-4324 · jvechinski@wisc.edu
Similar studies in Wisconsin
All healthy volunteers studies in Wisconsin →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How ASP3082 is Processed in Healthy Men
Astellas Pharma Global Development, Inc.
- Location
- Madison, WI
- Eligibility basics
- Ages 18–65 · Men only
- RecruitingHealthy volunteersPhase 1
A Trial of Lu AH69593 in Healthy Participants
H. Lundbeck A/S
- Location
- Madison, WI
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- La Crosse, WI + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1
A Trial to Compare the Pharmacokinetics of Two Presentations of Navenibart in Healthy Participants
Astria Therapeutics, Inc.
- Location
- Madison, WI + 2 other US sites
- Eligibility basics
- Ages 18–55